Middle East and Africa Kidney Disease Market Segments and Growth by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

  • Report Code : TIPRE00016075
  • Category : Life Sciences
  • No. of Pages : 164
Buy Now

The Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.

Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.

Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)

Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Increased Prevalence of Obesity across the Region

Every country in the Middle East & Africa region is currently facing an increasing prevalence of obesity due to multiple factors. A sedentary lifestyle and unhealthy eating habits contribute majorly to obesity in an individual. Along with a lack of physical activity and mounting stress are contributing as well. According to a report ‘2018ReviewEnd-stage Renal Disease in the Middle East: A Systematic Review and Meta-analysis’, it is estimated that the annual cost for CKD and ESRD is $48 billion and $32.9 billion and is rising due to cases of obesity.As perthe report ‘Chronic Kidney Disease in Arab World: A Call for Action,’obesity is also related to CKD epidemiology since obesity appears to be an essential risk factor for CKD. The prevalence of obesity has increased over the past two decades. Over 3,000 million adults worldwide are obese. The majority of a body mass index of at least 35 among incident dialysis patients has increased by 64% over the past decade. If trends continue, 20% of all patients will initiate dialysis with this degree of obesity. In Syria, obesity was 38.2%, with the prevalence in women nearly one and half times more than in men. Obesity affects 16–50% of individuals with diabetes in the Arab world, 20–38% have hyperlipidemia, 24–46% have hypertension and, although data are incomplete, nephropathy and retinopathy rates appear to be relatively high. Moreover, in a review of obesity prevalence in the Arab world, it was concluded that one-third of Arabs are obese, and women have notably higher rates of obesity as defined by a body mass index of 30.Thus, an increase in the prevalence of obesity in the Middle East & Africa region is likely to create lucrative opportunities for market growth.

Product- Based Market Insights

Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End-User - Based Market Insights

Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027

Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Middle East and Africa Kidney Disease Market: Strategic Insights

Middle East and Africa Kidney Disease Market
  • Market Size 2019
    US$ 4,834.1 Million
  • Market Size 2027
    US$ 7,406.2 Million

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Regional Overview

Regional Overview
  • Middle East and Africa

Market Segmentation

Market SegmentProduct
  • Diagnosis and Treatment
Market SegmentEnd User
  • Hospitals
  • Diagnostic Laboratories
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Middle East and Africa Kidney Disease MarketReport Scope

Middle East and Africa Kidney Disease Market Report Scope

Report Attribute Details
Market size in 2019 US$ 4,834.1 Million
Market Size by 2027 US$ 7,406.2 Million
Global CAGR (2020 - 2027) 5.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Diagnosis and Treatment
By End User
  • Hospitals
  • Diagnostic Laboratories
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    middle-east-and-africa-kidney-disease-market-report-deliverables-img1
    middle-east-and-africa-kidney-disease-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Product, End User, and Country

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    Saudi Arabia

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Middle East and Africa Kidney Disease Market
    Connect With Expert

    The List of Companies - Middle East and Africa Kidney Disease Market

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. AbbVieInc
    4. Pfizer Inc
    5. Teva Pharmaceutical Industries Ltd
    6. GlaxoSmithKline plc
    7. Sysmex Corporation
    8. Siemens AG
    9. Amgen Inc